Genertec Universal Medical Group Company Limited (UMTAF) Investment Research Dashboard
About Genertec Universal Medical Group Company Limited (UMTAF) stock analysis
Get live UMTAF stock price $0.59, comprehensive Genertec Universal Medical Group Company Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time UMTAF stock data and investment insights.
Loading chart data...
Genertec Universal Medical Group Company Limited (UMTAF) Overview
Genertec Universal Medical Group Company Limited (UMTAF) is a publicly traded company in the Financial Services sector , specifically within the Financial - Credit Services industry . As of the latest trading session, UMTAF trades at $0.59 with a market capitalization of 1.13B . Over the past 52 weeks, UMTAF has traded between $0.59 and $0.59 , with the current price positioned at approximately...
Key Takeaways
- Operates in the Financial Services sector (Financial - Credit Services)
- Market cap: 1.13B
- Current price: $0.59
- 52-week range: $0.59 - $0.59
- P/E ratio: 4.58
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Genertec Universal Medical Group Company Limited (UMTAF), established in 1984 and headquartered in Beijing, China, delivers a comprehensive suite of financial and advisory services throughout the People's Republic of China, primarily targeting the me...
Company Information
- CEO
- Wang Wenbing
- Sector
- Financial Services
- Industry
- Financial - Credit Services
- Employees
- 21089
Contact Information
- Website
- https://www.umcare.cn
- Address
- West Wing of Hademen Plaza
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 4.6)
✓ Lower volatility stock (Beta: 0.69) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Genertec Universal Medical Group Company Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Genertec Universal Medical Group Company Limited
- ⚠Investors should consider how Genertec Universal Medical Group Company Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.13B
P/E Ratio (TTM)
4.58
Beta
0.69
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare UMTAF with peer companies:
- Price
- $3.05+0.00% (1D)
- Market cap
- 1.46B
- Price
- $5.00+0.00% (1D)
- Market cap
- 702.74M
- Price
- $2.18+0.00% (1D)
- Market cap
- 1.76B
- Price
- $3.60+0.00% (1D)
- Market cap
- 1.18B
- Price
- $32.52+0.00% (1D)
- Market cap
- 1.24B
- Price
- $4.70+0.00% (1D)
- Market cap
- 1.14B
- Price
- $0.30+0.00% (1D)
- Market cap
- 39.99M
- Price
- $1.44+0.00% (1D)
- Market cap
- 759.68M
- Price
- $6.74+0.00% (1D)
- Market cap
- 1.25B
- Price
- $0.99+0.00% (1D)
- Market cap
- 746.00M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
86/100 ⭐⭐⭐⭐⭐
- Overall
- -0.1%
- NYSE
- +0.1%
- NASDAQ
- -0.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Consumer Defensive | +1.3% | +3.3% | +2.2% | 29.2 | 88/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.1% | +0.9% | +2.0% | 19.3 | 86/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.4% | -1.6% | +2.0% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.1% | +0.5% | +0.8% | 23.5 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | -0.7% | +0.1% | -1.3% | 24.9 | 60/100⭐⭐⭐⭐ |
| Energy | -0.4% | -2.0% | -2.4% | 19.4 | 51/100⭐⭐⭐ |
| Utilities | -1.5% | -0.5% | -4.9% | 25.4 | 40/100⭐⭐⭐ |
| Real Estate | -1.6% | -1.1% | -3.5% | 29.4 | 36/100⭐⭐ |
| Industrials | -0.4% | -0.5% | -10.7% | 30.5 | 19/100⭐ |
| Consumer Cyclical | -0.3% | -2.3% | -6.5% | 43.1 | 17/100⭐ |
| Technology | -1.9% | -4.0% | -9.4% | 41.9 | 7/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.